AQN vs CWEN-A

The deterministic health scores indicate significant concerns, with a Piotroski F-Score of 4/9 signaling borderline financial stability and no available Altman Z-Score limiting distress risk assessment. Despite a recent 1Y price surge of +47.5%, the stock trades at a steep valuation (P/E 91.14 vs sector avg 19.73) while reporting a negative profit margin (-1.11%) and an unsustainable dividend payout ratio (371.43%). However, strong operating metrics like 25.07% operating margin, improving EPS trends (+12.5% YoY), and a 4.06% dividend yield provide some support. The lack of insider activity and mixed analyst sentiment (hold) further justify a cautious stance.

CWEN-A exhibits a significant valuation disconnect, trading at $39.55 despite a Graham Number of $22.76 and an Intrinsic Value of $10.01. While the Piotroski F-Score of 4/9 indicates stable financial health, the company suffers from a negative ROE (-4.03%) and an unsustainable dividend payout ratio of 123.64%. Strong revenue growth (21.10%) is offset by extreme earnings volatility and a bearish technical trend (10/100). The stock appears heavily overvalued based on deterministic metrics, despite the 'strong_buy' analyst consensus.